Skip to main content
Clinical Trials/ACTRN12621000858897
ACTRN12621000858897
Completed
N/A

Feasibility and effects of an exercise program delivered before treatment commencement in people with lung cancer.

South Metropolitan Health Service0 sites7 target enrollmentJuly 2, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Inoperable lung Cancer
Sponsor
South Metropolitan Health Service
Enrollment
7
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 2, 2021
End Date
January 11, 2022
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria will comprise adults (i) with primary non\-small cell lung cancer, (ii) Eastern Cooperative Organisation Group (ECOG) performance status between 0 and 2 (scales ranges between 0 and 4, with lower scores indicating better performance status); and (iii) referred to treatments other than lung resection at FSH.

Exclusion Criteria

  • Patients with brain metastasis, acute illness or any musculoskeletal, cardiovascular (symptomatic heart disease) or neurological disorder that could inhibit performing exercise will be excluded. For those patients willing to exercise at one of the Community Physiotherapy Service sites, an additional exclusion criterion is resting peripheral oxygen saturation (SpO2\) less than or equal to 91%, and SpO2 less than or equal to 85% during the 6\-minute walk test. Further, participants will be required to complete questionnaires and understand instructions, which require them to be able to read and understand English. Therefore, we are specifically excluding people who have an inability to read and understand English.

Outcomes

Primary Outcomes

Not specified

Similar Trials